Graves Disease
📧 Sign up to get email alerts when something new happens for Graves Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
A prospective observational trial investigating carotid intima-media thickness in patients undergoing thyroid surgery has been withdrawn.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
A clinical trial investigating immunological markers linked to mental fatigue in Graves' disease (including Graves' ophthalmopathy) that is …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease [NA]
A clinical trial is recruiting to evaluate Rubus Sanctus (wild blackberry) root extract as a dietary supplement for Graves' disease.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Prospective Evaluation of OptiThyDose [NA]
A prospective evaluation of OptiThyDose for thyroid conditions, including congenital hypothyroidism and Graves' disease, is currently recrui…
-
FDA approval · 2025-08-26FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for methimazole (generic) submitted by NorthStar RX LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease [EARLY_Phase 1]
An early-phase allogeneic anti-CD19 CAR-T therapy is being studied for refractory Graves' disease, and the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
This recruiting clinical trial studies the progression of inflammatory orbitopathy (Graves' orbitopathy) and the biological progression of p…
-
FDA approval · 2025-07-21FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
FDA supplemental approval for Methimazole involving Chartwell RX, LLC under an ANDA, confirming regulatory status for a generic methimazole …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
This clinical trial update describes a Minia University-sponsored study assessing how common incidental thyroid cancer is among patients wit…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China
A clinical follow-up study on drug therapy for Graves' disease in China is currently recruiting participants.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
A clinical trial is currently recruiting to evaluate thyroidectomy as a treatment option for Graves' disease and amiodarone-induced thyrotox…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Evaluating an AI Tool for Detecting Thyrotoxic States
An ongoing clinical trial sponsored by THYROSCOPE INC. is evaluating an AI tool to detect thyrotoxic states in Graves' disease and hyperthyr…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz [Phase 2]
A Phase 2 study evaluating WP1302 to prevent relapse after methimazole withdrawal in Graves' disease is suspended.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Preoperative Corticosteroids in Autoimmune Thyroid Disease [Phase 4]
Phase 4 clinical trial evaluating the use of preoperative corticosteroids in autoimmune thyroid disease, including Graves' disease and Hashi…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Cardiac Symptoms in Patients With Treated Graves' Disease
Clinical trial update describing cardiac symptoms in patients treated for Graves' disease; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism [NA]
A completed clinical trial comparing selenium supplementation to placebo in Graves' disease (Graves' hyperthyroidism). The document snippet …
-
FDA approval · 2025-02-05FDA Approved: METHIMAZOLE — Original Application (Viona Pharmaceuticals Inc.)
FDA approves an original ANDA for methimazole from Viona Pharmaceuticals Inc., for the treatment of hyperthyroidism (including Graves' disea…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Efficacy of Methimazole Dosing Algorithm
A terminated clinical trial evaluating a methimazole dosing algorithm for Graves' disease; no definitive efficacy data is provided in the up…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
A clinical trial is recruiting to validate immunological markers associated with mental fatigue in Graves' disease.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy? [Phase 3]
A Phase 3 trial investigated whether potassium iodide (SSKI) can reduce vascularity in Graves' thyroidectomy; the study was terminated and r…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Iodine Supplementation in Graves' Hyperthyroidism [NA]
A clinical trial update notes a study on iodine supplementation for Graves' disease and hyperthyroidism that has not yet begun recruiting.
-
CLINICAL_TRIALS other · 2024-08-05Clinical Trial Update: Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders [NA]
A clinical trial from Assiut University is evaluating embolization of thyroid arteries as a treatment for Graves' disease, nodular goiter, m…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease [NA]
A prospective study evaluating microwave ablation for relapsed Graves' disease is currently recruiting, sponsored by The University of Hong …
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Assessment of Thyroid Doppler Ultrasound in Followup of Pediatric Graves' Disease
Clinical trial update describing a study at Assiut University evaluating thyroid Doppler ultrasound as a follow-up method in pediatric Grave…
-
FDA approval · 2024-06-26FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Propylthiouracil from Macleods Pharmaceuticals Limited (ANDA208867).